MEDICINOVA, INC. Deferred Income Tax Liabilities, Net
MEDICINOVA, INC. (MNOV) had Deferred Income Tax Liabilities, Net of $201.79 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredIncomeTaxLiabilitiesNet · last filed 2026-08-13
- 2026-06-30: Deferred Income Tax Liabilities, Net $201.79K.
- 2026-03-31: Deferred Income Tax Liabilities, Net $201.79K.
- 2025-12-31: Deferred Income Tax Liabilities, Net $201.79K.
- 2025-09-30: Deferred Income Tax Liabilities, Net $201.79K.
| Period end | Deferred Income Tax Liabilities, Net |
|---|---|
| 2026-06-30 | $201.79K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $201.79K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $201.79K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $201.79K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $201.79K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $201.79K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $201.79K 10-K · filed 2026-03-10 |
| 2024-09-30 | $201.79K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $201.79K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $201.79K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $201.79K 10-K · filed 2025-02-19 |
| 2023-09-30 | $201.79K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $201.79K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $201.79K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $201.79K 10-K · filed 2024-02-15 |
| 2022-09-30 | $201.79K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $201.79K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $201.79K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $201.79K 10-K/A · filed 2023-03-28 |
| 2021-09-30 | $201.79K 10-Q · filed 2021-11-12 |
| 2021-06-30 | $201.79K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $201.79K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $201.79K 10-K · filed 2022-02-16 |
| 2020-09-30 | $201.79K 10-Q · filed 2020-10-26 |
| 2020-06-30 | $201.79K 10-Q · filed 2020-07-28 |
| 2019-12-31 | $201.79K 10-K · filed 2021-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |